EP3067066
Forvarnir og meðferð við sjúkdómum sem einkennist af sýnúklein vefjaskemmdum og mýlidismydun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.2.2008EP published:
27.3.2019EP application number:
16154617.1
EP translation filed:
24.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
21.2.2028Expiry date:
21.2.2026Next due date:
28.2.2026
Title:
PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
Timeline
Today
22.2.2008EP application
27.3.2019EP Publication
24.5.2019Translation submitted
15.6.2019Registration published
21.2.2026Expires
Owner
Name:
Prothena Biosciences LimitedAddress:
77 Sir Rogerson's Quay Block C Grand Canal Docklands, Dublin 2, D02 T804, IE
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, 94607, Oakland, CA, US
Inventor
Name:
SCHENK, Dale B.Address:
Burlingame, CA, US
Name:
MASLIAH, EliezerAddress:
San Diego, AZ, US
Name:
BUTTINI, Manuel, J.Address:
Esch-sur-Alzette, LU
Name:
CHILCOTE, Tamie J.Address:
San Francisco, CA, US
Name:
ROCKENSTEIN, EdwardAddress:
Chula Vista, CA, US
Name:
GAMES, Kate DoraAddress:
Belmont, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
710248Date:
23.2.2007Country:
US
Number:
697646Date:
6.4.2007Country:
US
Number:
984721 PDate:
1.11.2007Country:
US
Classification
Categories:
A61K 39/395, C12P 21/04, C12P 21/08, C07K 16/18, C07K 16/28, A61P 25/16, A61P 25/28, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 14.1.2020
Expires: 21.2.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 12.1.2021
Expires: 21.2.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.1.2022
Expires: 21.2.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.1.2023
Expires: 21.2.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.1.2023
Expires: 21.2.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 22.1.2024
Expires: 21.2.2025
Payer: Acumass
Number: 18
Paid: 17.1.2025
Expires: 21.2.2026
Payer: Acumass